Access to medicines and domestic compulsory licensing: Learning from Canada and Thailand

Global Public Health

Volumn 6, Issue 2, 2011, Pages 111-124

  Kuek, V ^a   Phillips, K ^a   Kohler, J C ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Canada; Compulsory licensing; Medicines access; Pharmaceutical policy; Public health; Thailand; Trips

Indexed keywords

ARTICLE; CANADA; DRUG MANUFACTURE; HEALTH CARE ACCESS; HEALTH CARE POLICY; HUMAN; LICENSING; MEDICINE; PRIORITY JOURNAL; THAILAND;

CANADA; DRUG INDUSTRY; DRUGS, ESSENTIAL; HUMANS; INTERNATIONAL COOPERATION; LICENSURE, PHARMACY; PUBLIC HEALTH; PUBLIC POLICY; THAILAND; WORLD HEALTH;

EID: 79551617008     PISSN: 17441692     EISSN: 17441706     Source Type: Journal    
DOI: 10.1080/17441690903575255     Document Type: Article

References (44)

1. Agovino, T., 2007. Investors criticize Abbott [online]. New York: Associated Press. Available from: http://www.signonsandiego.com/news/business/20070322-1216- bbott-thailandinvestors.html [Accessed 18 January 2009].
2. Ahuja, A., 2007. Thai health groups urge Abbott boycott [online]. New York: Associated Press. Available from: http://lists.essential.org/pipermail/ip-health/2007-March/010799.html [Accessed 18 January 2009].
3. Baker, B., 2007. A new low in the pharma drug wars - Abbott withdraws seven medicines in Thailand [online]. New York: Health GAP. Available from: http://lists.essential.org/ pipermail/ip-health/2007-March/010771.html [Accessed 18 January 2009].
4. Canada Commission of Inquiry on the Pharmaceutical Industry, 1984. Report of the commission of inquiry on the pharmaceutical industry. Ottawa.
5. Canada House of Commons Special Committee on Drug Costs and Prices, 1967. Second (final) report of the Special Committee of the House of Commons on drug costs and prices: session 1966-67. Ottawa.
6. Canada Restrictive Trade Practices Commission, 1963. Report concerning the manufacture, distribution and sale of drugs. Ottawa.
7. Canada Royal Commission on Health Services, 1964. Royal commission on health services: 1964: Volume I and 1965: Volume 2. Ottawa.
8. Canada Royal Commission on Patents and Copyrights and Industrial Designs, 1960. Royal Commission on Patents, Copyrights and Industrial Designs report. Ottawa.
9. Cawthorne, P., Ford, N., and Limpananont, J., 2007. WHO must defend patients' interests, not industry [online]. The Lancet. Available from: http://www.essentialdrugs.org/edrug/archive/200703/msg00088.php [Accessed 25 March 2007].
10. Consumer and Corporate Affairs Canada, 1976. Working paper on patent law reform. Ottawa.
11. Denmark Ministry of Foreign Affairs, 2006. Sector overview pharmaceutical industry [online]. Available from: http://www.ambbangkok.um.dk/NR/rdonlyres/4EC3899D-14E5-474DB562- C5048792D722/0/SectorOverview PharmaceuticalIndustryJune2006.pdf [Accessed 7 August 2009].
12. Espicom Market Report, 2009. The pharmaceutical market: Thailand. Rockville, MD: Espicom.
13. Essential Action, 2008. Thailand lowers medicine prices; faces U.S./E.U. pressure [online]. Global Access to Medicines Bulletin. Available from: http://www.essentialaction.org/access/ index.php?/archives/135-Global-Access-to-Medicines-Bulletin-Thailand-Lowers-Medicine- Prices;-Faces-U.S.E.U.-Pressure.html [Accessed 18 January 2009].
14. Gorecki, P., 1981. Regulating the price of prescription drugs in Canada: compulsory licensing, product selection, and government reimbursement programs. Economic Council of Canada, Technical Report No. 8. Ottawa.
15. Gorecki, P. and Henderson, I., 1981. Compulsory patent licensing of drugs in Canada: a comment on the debate. Canadian Public Policy/Analyse de Politiques, 7 (4), 559-568.
16. Harrison, C., 2001. Protection of pharmaceuticals as foreign policy: the Canada-U.S. Trade Agreement and Bill C-22 versus the North American Free Trade Agreement and Bill C-91. North Carolina Journal of International Law and Commercial Regulation, 26, 457-529.
17. Health Development Networks, 2007. Is compulsory licensing the solution to patient access to medicines [online]. SEA-AIDS. Available from: http://www.healthdev.org/viewmsg. aspx?msgid-A0388CE8-6E44-4654-9202-20088E21C6C0 [Accessed 18 January 2009].
18. Knowledge Exchange Initiative, 2007. Notes from March 16th 2007 U.S. Capitol briefing on Thailand's compulsory licenses [online]. Available from: http://www.keionline.org/index php?option-com-content&task-view&id-37 [Accessed 18 January 2009].
19. Lexchin, J., 1992. Pharmaceuticals, patents and politics: Canada and Bill C-22. Canadian Centre for Policy Alternatives. Ottawa.
20. Lexchin, J., 1997. After compulsory licensing: coming issues in Canadian pharmaceutical policy and politics. Health Policy, 40, 69-80.
21. McFetridge, D., 1998. Intellectual property, technology, diffusion, and growth in the Canadian economy. In: R. Anderson and N. Gallini, eds. Competition policy and intellectual property rights in the knowledge-based economy. Calgary: University of Calgary Press, 65-103.
22. Medécins sans Frontières [MSF], 2007. Thailand, Abbott and the second line AIDS crisis [online]. Medécins sans Frontières Briefing Note 7. Available from: http://www.doctors withoutborders.org/news/access/thailand-briefingdoc-04-11-2007.cfm [Accessed 18 January 2009].
23. North American Free Trade Agreement 32 International Legal Materials (I.L.M.) 289, (1993) (table of contents, preamble, Parts I-III); 32 I.L.M. 605 (1993) (Parts IV-VII, Annexes) [online]. Available from: http://www.nafta-sec-alena.org/DefaultSite/index-e.aspx?DetailID-78 [Accessed 15 July 2008].
24. Ogilvy Renault, 2002. Evolution of Canadian legislation affecting innovative drug patents [online]. Available from: http://www.ogilvyrenault.com/en/resourceCentre-1562.htm [Accessed 18 January 2009].
25. Patent Act B.E. 2522 (1979) (Thailand).
26. Patent Act, R.S.C. (1952) c. 203 (Canada).
27. Pharmalot, 2007. Abbott lowers price of Kaletra AIDS drug [online]. Available from: http:// pharmalot.com/2007/04/abbott-lowers-price-of-kaletra.php [Accessed 18 January 2009].
28. Reichman, J., 2002. Non-voluntary licensing of patented inventions: the Canadian experience [online]. UNCTAD/ICTSD Capacity Building Project on Intellectual Property Rights and Sustainable Development. Available from: http://www.iprsonline.org/unctadictsd/docs/ reichman-hasenzahl-Canada.pdf [Accessed 18 January 2009].
29. Research and Markets, 2009. Thailand pharmaceuticals and healthcare report Q3 2009 [online]. Research and markets. Available from: http://finance.boston.com/boston/?GUID- 9382467&Page-MediaViewer&ChannelID-3191 [Accessed 7 August 2009].
30. Revenga, A., Over, M., Masaki, E., Peerapatanapokin, W., Gold, J., Tangcharoensathien, V., and Thanprasertsuk, S., 2006. The economics of effective AIDS treatment: evaluating policy options for Thailand [online]. World Bank Report No. 37449. Available from: http://web.worldbank.org/WBSITE/EXTERNAL/COUNTRIES/EASTASIAPACIFICEXT/EXTEAPREGTOPHEANUT/EXTEAPREGTOPHIVAIDS/0,contentMDK:21024879-pagePK:34004173-piPK:34003707-theSitePK:503157,00.html [Accessed 21 August 2008].
31. Scherer, F., 2003. The economics of compulsory drug patent licensing [online]. Working Group 4 of the Commission for Macroeconomics and Health of the World Trade Organisation. Available from: http://wbln0018.worldbank.org/HDNet/hddocs.nsf/9b2b70eeb6c333fb852568aa0073e2a1/2adc484a5d57888f85256d350054080f/$FILE/F.M.%20Scherer%20-%20paper.doc [Accessed 19 April 2008].
32. Stevens, P., 2007. Will compulsory licenses improve treatment for patients? The case of Thailand [online]. Campaign for Fighting Diseases. Available from: http://www.fightingdiseases.org./pdf/Stevens-thailand-web.pdf [Accessed 12 August 2009].
33. Thailand Department of Disease Control, 2006. Announcement of the Department of Disease Control, Ministry of Public Health, Thailand on the public use of patent for pharmaceutical products [online]. CPTech. Available from: http://www.cptech.org/ip/health/c/thailand/thaicl4efavirenz.html [Accessed 9 October 2008].
34. Thailand Department of Disease Control, 2007. Decree of Department of Disease Control, Ministry of Public Health regarding exploitation of patent on drugs & medical supplies by the Government on combination drug between Lopinavir & Ritonavir [online]. CPTech. Available from: http://www.cptech.org/ip/health/c/thailand/thai-cl-kaletra-en.pdf [Accessed 9 October 2008].
35. Thailand Ministry of Public Health, 2007a. Thailand's efforts to obtain life-saving drugs at reduced prices [online]. Available from: http://thailand.prd.go.th/print.php?id-1914&type-inside [Accessed 17 August 2009].
36. Thailand Ministry of Public Health, 2007b. 25 January, B.E.2550. Ministry of Public Health Announcement regarding exploitation of patents on drugs and medical supplies for Clopidogrel [online]. CPTech. Available from: http://www.cptech.org/ip/health/c/thailand/thai-cl-clopidogrel-en.pdf [Accessed 9 October 2008].
37. Thailand Ministry of Public Health and the National Health Security Office, 2007. Facts and evidences on the 10 burning issues related to the government use of patents on three patented essential drugs in Thailand - document to support strengthening of social wisdom on the issue of drug patent [online]. Available from: http://www.essentialaction.org/access/uploads/thaicl-white-paper.pdf [Accessed 15 July 2008].
38. Tunsarawuth, S., 2008. Thailand avoids compulsory licence on cancer drug; 3 more drugs undecided [online]. Intellectual Property Watch. Available from: http://www.ip-watch.org/weblog/index.php?p-906 [Accessed 9 October 2008].
39. USA for Innovation, 2007. USA for Innovation ad campaign highlights Thailand's theft of American assets over 35,000 letters sent to President Bush and U.S. [online]. USA for Innovation press release. Available from: http://usaforinnovation.org/news/display-article.cfm?ID-20 [Accessed 18 January 2009].
40. US Federal Trade Commission, 1998. In re satellite carrier compulsory license; definition of unserved household; Docket No. RM 98-1; reply comments of the staff of the Federal Trade Commission [online]. USA. Available from: http://www.ftc.gov/be/v980004.shtm [Accessed 7 August 2009].
41. United States Trade Representative [USTR], 2007. National trade estimate on foreign trade barriers 2007 report: Thailand [online]. USTR. Available from: http://www.ustr.gov/assets/Document-Library/Reports-Publications/2008/2008-NTE-Report/asset-upload-file823-14611.pdf [Accessed 11 August 2008].
42. Velasquez, G., Aldis, B., Timmermans, K., Oh, C., Adachi, K., Kampf, R., and Seuba, X., 2008. Improving access to medicines in Thailand: the use of TRIPS flexibilities [online]. WHO mission in Bangkok report. Available from: http://www.keionline.org/index.php?option-com-content&task-view&id-90 [Accessed 16 October 2008].
43. WHO, 2004-2007. WHO medicines strategy: countries at the core 2004-2007 [online]. WHO/ EDM/2004.5. Available from: http://www.who.int/medicinedocs/en/d/Js5571e/#Js5571e [Accessed 15 December].
44. WTO, 1994. Agreement on trade-related aspects of Intellectual Property Rights, 15 April 1994, Annex 1C of the Marrakesh Agreement establishing the World Trade Organisation [online]. WTO Document LT/UR/A-1C/IP/1. Available from: http://docsonline.wto.org [Accessed 18 January 2009].